24th Annual Conference of the European Society for Clinical Virology, Manchester, İngiltere, 7 - 10 Eylül 2022, ss.186
Aim: The
spike (S) protein of SARS-CoV-2, and Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine
2 (TMPRSS2) genetic variations may
act as a barrier in infection or to determine susceptibility to COVID-19
infection. In this context, we investigated the relationship between the
expression patterns and polymorphisms of the ACE2 and TMPRSS2 receptor
genes associated with COVID-19 and the clinical course of COVID-19 infection.
Methods: ACE2 and TMPRSS2 expressions were determined using the One-Run Real-Time Quantitative
Polymerase Chain Reaction (RT-Q-PCR) kit. Genotypic distributions of single
nucleotide polymorphisms of ACE2
rs714205, rs73635825, rs2285666, rs1978124, and TMPRSS2 rs8134378, rs2070788, rs7364083, rs13052975, rs9974589 were
obtained RT-PCR.
Results: The
expression of ACE2 and TMPRSS2 was different between SARS-CoV-2
positive and negative groups. ACE2
and TMPRSS2 expressions of SARS-CoV-2
positive patients treated in the intensive care unit were higher than the
control group and other patient groups. ACE2
rs714205GG genotype and G-allele showed significant differences in the
SARS-CoV-2 positive asymptomatic group. A significant correlation was found
between TMPRSS2 rs8134378GA,
rs2070788GA, rs7364083GA and rs9974589AC genotypes and SARS-CoV-2 positivity.
The rs1978124 C-allele and rs8134378 A-allele were significant in the
SARS-CoV-2 positive symptomatic group. TMPRSS2
rs2070788GA was different in all groups from the control group.
Conclusions: ACE2 rs714205GG may be protective from
COVID-19 infection, and TMPRSS2
rs2070788GA, rs8134378GA and rs9974589AC may be genotypes associated with
infection susceptibility. In conclusion, identifying the relationship between
host genetic variants and COVID-19 susceptibility will contribute to further
studies that will enable new vaccines and potential therapeutic approaches to
be applicable.